celgene uk manufacturing limited
celgene uk manufacturing limited Company Information
Company Number
05262329
Website
www.celgene.co.ukRegistered Address
7 albemarle street, london, W1S 4HQ
Industry
Manufacture of pharmaceutical preparations
Telephone
01895523000
Next Accounts Due
March 2025
Group Structure
View All
Shareholders
celgene uk holdings ltd 100%
celgene uk manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of CELGENE UK MANUFACTURING LIMITED at £0 based on a Turnover of £0 and 1.24x industry multiple (adjusted for size and gross margin).
celgene uk manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of CELGENE UK MANUFACTURING LIMITED at £0 based on an EBITDA of £-53.4k and a 5.4x industry multiple (adjusted for size and gross margin).
celgene uk manufacturing limited Estimated Valuation
Pomanda estimates the enterprise value of CELGENE UK MANUFACTURING LIMITED at £50.7m based on Net Assets of £20.2m and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Celgene Uk Manufacturing Limited Overview
Celgene Uk Manufacturing Limited is a live company located in london, W1S 4HQ with a Companies House number of 05262329. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in October 2004, it's largest shareholder is celgene uk holdings ltd with a 100% stake. Celgene Uk Manufacturing Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Celgene Uk Manufacturing Limited Health Check
Pomanda's financial health check has awarded Celgene Uk Manufacturing Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 1 areas for improvement. Company Health Check FAQs
2 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Celgene Uk Manufacturing Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (102)
- Celgene Uk Manufacturing Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Celgene Uk Manufacturing Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Celgene Uk Manufacturing Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4932 weeks, this is more cash available to meet short term requirements (11 weeks)
- - Celgene Uk Manufacturing Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.1%, this is a lower level of debt than the average (45.7%)
- - Celgene Uk Manufacturing Limited
- - Industry AVG
CELGENE UK MANUFACTURING LIMITED financials
Celgene Uk Manufacturing Limited's latest turnover from June 2023 is 0 and the company has net assets of £20.2 million. According to their latest financial statements, we estimate that Celgene Uk Manufacturing Limited has 1 employee and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | |||||||||||||
| Cost Of Sales | 0 | |||||||||||||
| Gross Profit | 0 | |||||||||||||
| Admin Expenses | -2,758 | |||||||||||||
| Operating Profit | -53,430 | -16,900 | -16,385 | -377 | 2,758 | -3,423 | -3,240 | -3,327 | -3,342 | -3,342 | -3,356 | -5,077 | -2,266 | |
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 20 | 2,449 | 2,594 | 1,675 | 1,617 | 1,553 | 699 | 0 | 0 | 0 |
| Pre-Tax Profit | -53,430 | -16,900 | -16,385 | -377 | 2,778 | -974 | -646 | -1,652 | -1,725 | -1,789 | -2,657 | -5,077 | -8,309 | -2,210 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -53,430 | -16,900 | -16,385 | -377 | 2,778 | -974 | -646 | -1,652 | -1,725 | -1,789 | -2,657 | -5,077 | -8,309 | -2,210 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55,103,319 | 0 | 0 |
| Retained Profit | -53,430 | -16,900 | -16,385 | -377 | 2,778 | -974 | -646 | -1,652 | -1,725 | -1,789 | -2,657 | -55,108,396 | -8,309 | -2,210 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | |||||
| EBITDA* | -53,430 | -16,900 | -16,385 | -377 | 2,758 | -3,423 | -3,240 | -3,327 | -3,342 | -3,342 | -3,356 | -5,077 | -2,266 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 10,145,484 | 65,248,803 | 65,248,803 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 17,793,521 | 10,145,484 | 65,248,803 | 65,248,803 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 2,427,145 | 2,427,145 | 2,427,145 | 2,427,145 | 2,427,163 | 2,427,145 | 2,427,145 | 2,427,146 | 2,427,146 | 2,427,145 | 2,427,146 | 3,505,957 | 2,427,145 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142 | 127 | 142 | 0 | 400,554 | 1,200,836 |
| Cash | 2,427,071 | 28,160 | 61,048 | 61,445 | 61,822 | 743,445 | 747,438 | 745,083 | 743,592 | 748,332 | 747,107 | 750,205 | 75,617 | 90,442 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,427,071 | 2,455,305 | 2,488,193 | 2,488,590 | 2,488,967 | 3,170,608 | 3,174,583 | 3,172,228 | 3,170,880 | 3,175,605 | 3,174,394 | 3,177,351 | 3,982,128 | 3,718,423 |
| total assets | 20,220,592 | 20,248,826 | 20,281,714 | 20,282,111 | 20,282,488 | 20,964,129 | 20,968,104 | 20,965,749 | 20,964,401 | 20,969,126 | 20,967,915 | 13,322,835 | 69,230,931 | 68,967,226 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 393 | 393 | 393 | 393 | 681,812 | 681,813 | 678,812 | 678,812 | 681,812 | 678,812 | 679,112 | 1,478,812 | 1,200,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 25,589 | 0 | 15,988 | 0 | 0 | 3,000 | 6,000 | 6,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 9,798 |
| total current liabilities | 25,589 | 393 | 16,381 | 393 | 393 | 684,812 | 687,813 | 684,812 | 681,812 | 684,812 | 681,812 | 682,112 | 1,481,812 | 1,209,798 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 25,589 | 393 | 16,381 | 393 | 393 | 684,812 | 687,813 | 684,812 | 681,812 | 684,812 | 681,812 | 682,112 | 1,481,812 | 1,209,798 |
| net assets | 20,195,003 | 20,248,433 | 20,265,333 | 20,281,718 | 20,282,095 | 20,279,317 | 20,280,291 | 20,280,937 | 20,282,589 | 20,284,314 | 20,286,103 | 12,640,723 | 67,749,119 | 67,757,428 |
| total shareholders funds | 20,195,003 | 20,248,433 | 20,265,333 | 20,281,718 | 20,282,095 | 20,279,317 | 20,280,291 | 20,280,937 | 20,282,589 | 20,284,314 | 20,286,103 | 12,640,723 | 67,749,119 | 67,757,428 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -53,430 | -16,900 | -16,385 | -377 | 2,758 | -3,423 | -3,240 | -3,327 | -3,342 | -3,342 | -3,356 | -5,077 | -2,266 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -2,427,145 | 0 | 0 | 0 | -18 | 2,427,163 | 0 | -143 | 15 | -14 | 141 | -1,479,365 | 278,530 | 3,627,981 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 25,589 | -15,988 | 15,988 | 0 | -3,000 | 3,000 | 0 | 3,000 | 0 | 0 | 0 | 0 | -6,798 | 9,798 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 2,399,304 | -32,888 | -397 | -377 | -224 | -2,427,586 | -3,240 | -184 | -3,357 | -3,328 | -3,497 | 1,474,288 | -3,620,449 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 17,793,521 | 0 | 0 | 0 | 0 | 7,648,037 | -55,103,319 | 0 | 65,248,803 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -393 | 0 | 0 | 0 | -681,419 | 681,812 | 3,001 | 0 | -3,000 | 3,000 | -300 | -799,700 | 278,812 | 1,200,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 20 | 2,449 | 2,594 | 1,675 | 1,617 | 1,553 | 699 | 0 | 0 | 0 |
| cash flow from financing | -393 | 0 | 0 | 0 | -681,399 | 20,964,552 | 5,595 | 1,675 | -1,383 | 4,553 | 7,648,436 | -799,700 | 278,812 | 68,959,638 |
| cash and cash equivalents | ||||||||||||||
| cash | 2,398,911 | -32,888 | -397 | -377 | -681,623 | 743,445 | 2,355 | 1,491 | -4,740 | 1,225 | -3,098 | 674,588 | -14,825 | 90,442 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 2,398,911 | -32,888 | -397 | -377 | -681,623 | 743,445 | 2,355 | 1,491 | -4,740 | 1,225 | -3,098 | 674,588 | -14,825 | 90,442 |
celgene uk manufacturing limited Credit Report and Business Information
Celgene Uk Manufacturing Limited Competitor Analysis
Perform a competitor analysis for celgene uk manufacturing limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in W1S area or any other competitors across 12 key performance metrics.
celgene uk manufacturing limited Ownership
CELGENE UK MANUFACTURING LIMITED group structure
Celgene Uk Manufacturing Limited has 1 subsidiary company.
Ultimate parent company
CELGENE CORP
#0057132
2 parents
CELGENE UK MANUFACTURING LIMITED
05262329
1 subsidiary
celgene uk manufacturing limited directors
Celgene Uk Manufacturing Limited currently has 6 directors. The longest serving directors include Lynelle Hoch (Apr 2020) and Ms Katherine Kelly (Apr 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Lynelle Hoch | 51 years | Apr 2020 | - | Director | |
| Ms Katherine Kelly | United States | 48 years | Apr 2020 | - | Director |
| Mr John Cooke | United Kingdom | 54 years | Jul 2021 | - | Director |
| Ms Kimberly Jablonski | United States | 52 years | Jan 2022 | - | Director |
| Ms Annie Ong | England | 50 years | Nov 2023 | - | Director |
| Mr Guy Oliver | England | 46 years | Mar 2024 | - | Director |
P&L
June 2023turnover
0
0%
operating profit
-53.4k
+216%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
20.2m
0%
total assets
20.2m
0%
cash
2.4m
+85.19%
net assets
Total assets minus all liabilities
Similar Companies
celgene uk manufacturing limited company details
company number
05262329
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
October 2004
age
20
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
DELOITTE LLP
address
7 albemarle street, london, W1S 4HQ
Bank
-
Legal Advisor
-
celgene uk manufacturing limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to celgene uk manufacturing limited.
celgene uk manufacturing limited Companies House Filings - See Documents
| date | description | view/download |
|---|
